The Respiratory Care Device Market was esteemed at USD 21.5 billion in 2023, and is to reach USD 39.79 billion by 2031, enrolling an expected CAGR of 8% during the forecast period 2024-2031.
Respiratory Care Devices are utilized for analysis, observing, and therapy of respiratory infections like Chronic Obstructive Pulmonary Disease (COPD), asthma, tuberculosis, and pneumonia. These devices give improved care to patients experiencing such intense and constant respiratory illnesses. The report dissects the respiratory consideration gadgets market based on item type, end client, and geology.
Get more information on Respiratory Care Device Market - Request Sample Report
In any case, the advancement of the worldwide respiratory gadgets market is significantly determined by the expanded pervasiveness of respiratory infections, developing maturing populace across the globe, rising predominance of smoking, high contamination and urbanization, expanding frequency of preterm births, and way of life changes. As per this report Worldwide Respiratory Care Devices Market Size was US$ 22.35 Billion.
Key Driving Factors:
Flare-up of irresistible illnesses influencing the respiratory framework. Irresistible respiratory sicknesses straightforwardly drive interest for respiratory consideration. Coronavirus is the latest and critical of these sicknesses; the pandemic has brought about a flood popular for individual security hardware and ventilators, among others. The interest for ventilators has additionally become because of the COVID-19 flare-up, bringing about administrative and modern help for driving the speed of assembling. This is characteristic of the accentuation on respiratory consideration behind the scenes of a flare-up; the market is supposed to show a solid development rate, subsequently.
Restraining factor:
Numerous patients depend on repayments to get treatment. The analytic business all in all and respiratory care device, specifically, is as of now confronting the test of absence of repayments for different demonstrative tests. Repayment arrangements are scattered in Europe and are accessible just for PAP gadgets and oral machines in select nations (gadgets that are not covered by protection have a low piece of the pie in the area). Likewise, most of nations in the Asian and RoW districts have insignificant repayment inclusion for respiratory care device
Opportunities:
The quick development in the worldwide geriatric populace, rising frequency of constant illnesses (counting COPD and asthma), and the expense benefits of home consideration gadgets and administrations (contrasted with clinic visits) are the key variables driving the development of the home medical services market. The high development potential in developing business sectors, medical services decentralization, and the advancement of scaled down gadgets are a portion of the main considerations that are supposed to give huge learning experiences to players working in the respiratory home medical care market. Attributable to the rising medical services costs, an enormous number of patients experiencing persistent respiratory infections like to go through therapies in home consideration settings. This pattern is supposed to build the interest for items like nebulizers, ventilators, and CPAP gadgets, as they are utilized by patients to treat, analyze, and screen an assortment of respiratory illnesses in home consideration settings.
Challenges:
Regardless of the great commonness of major respiratory sicknesses, for example, asthma and COPD remain profoundly underdiagnosed and undertreated. This is especially clear in creating economies because of the low mindfulness about these sicknesses and the inaccessibility of sufficient assets to analyze these infections. As indicated by the WHO, over 90% of COPD passings and 80% of asthma passings happen in low-and center pay nations. COPD grows gradually, and it is normally analyzed in individuals matured more than 40 years, which makes it challenging to control in the later phases of life. It is assessed that around 70% of COPD patients are underdiagnosed inferable from the absence of mindfulness about the infection. Like COPD, asthma is additionally a profoundly underdiagnosed and undertreated infection (in around half asthmatics).
COVID-19 is the latest and huge of these illnesses; the pandemic has brought about a flood sought after for respiratory consideration hardware like Nebulizers, Pulse Oximeters, and ventilators, among others. The requirement for ventilators has likewise ascended because of the COVID-19 pandemic, bringing about administrative and modern help for moving the speed of assembling. It communicates the accentuation on respiratory care behind the scenes of a pandemic the respiratory care gadgets market has shown sound development.
By Product:
Therapeutic Devices
Monitoring Devices
Diagnostic Devices
Consumables and Accessories
By Indication:
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Sleep Apnea
Infectious Disease
Others
By End-User
Hospitals
Home Care Settings
Ambulatory Care Centers
Others
Around the world, North America held the biggest respiratory consideration gadgets market. This is basically ascribed to the rising majority of respiratory illnesses like Chronic Obstructive Pulmonary Disease (COPD). According to CDC (Centers for Diseases Control and Prevention), ongoing obstructive aspiratory illness is the fourth most reason for death in the US. COPD influences 15 million American and a bigger number of than 150,000 Americans pass on from COPD every year.
Moreover, the Asia-Pacific district features gigantic development because of an enormous pool of respiratory patients, air contamination, and the developing commonness of tobacco smoking. Additionally, APAC is advancing into a clinical the travel industry center point and is viewed as one of the quickest developing business sectors for clinical gadgets. Low framework and therapy costs and the accessibility of profoundly taught doctors have driven clinical travelers to APAC nations, especially Thailand and India.
Need any customization research on Respiratory Care Device Market - Enquiry Now
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
The Major Players are Koninklijke Philips N.V., ResMed, Medtronic, Fisher and Paykel Healthcare Limited, BD, Chart Industries Inc., Drägerwerk, AG & Co. KGaA, Hamilton Medical, Teleflex Incorporated, 3M and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 21.5 Billion |
| Market Size by 2031 | US$ 39.79 Billion |
| CAGR | CAGR of 8% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Therapeutic Devices, PAP Devices, Ventilators, Nebulizers, Humidifiers, Oxygen Concentrators, Inhalers, Reusable, Resuscitators, Nitric Oxide Delivery Units, Oxygen Hoods) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Koninklijke Philips N.V., ResMed, Medtronic, Fisher and Paykel Healthcare Limited, BD, Chart Industries Inc., Drägerwerk, AG & Co. KGaA, Hamilton Medical, Teleflex Incorporated, 3M |
Ans: The Respiratory Care Device Market size is to grow at a CAGR of 8% during the forecast period 2024-2031.
Key players in the respiratory care device market device are Koninklijke Philips N.V., Res Med, Medtronic, Fisher, Pay Kel Healthcare Limited, BD, and Chart Industries, Inc.
By-products sub-segments are therapeutic devices, monitoring devices, diagnostic devices, consumables, and accessories. The therapeutic devices segments have the largest revenue share of the respiratory care device market.
The market is divided into three segments are by product type, by indication, and by end users.
Ans: The Respiratory Care Device market was valued at US$ 21.5 Bn in 2023.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia war
4.3 Impact of ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Global Respiratory Care Device Market Segmentation on the basis of Product:
8.1 Therapeutic Devices
8.2 Monitoring Devices
8.3 Diagnostic Devices
8.4 Consumables and Accessories
9. Global Respiratory Care Device Market Segmentation on the basis of Indication:
9.1 Chronic Obstructive Pulmonary Disease (COPD)
9.2 Asthma
9.3 Sleep Apnea
9.4 Infectious Disease
9.5 Others
10. Global Respiratory Care Device Market Segmentation on the basis of End-User
10.1 Hospitals
10.2 Home Care Settings
10.3 Ambulatory Care Centers
10.4 Others
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 USA
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Italy
11.3.5 Spain
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 South Korea
11.4.3 China
11.4.4 India
11.4.5 Australia
11.4.6 Rest of Asia-Pacific
11.5 The Middle East & Africa
11.5.1 Israel
11.5.2 UAE
11.5.3 South Africa
11.5.4 Rest
11.6 Latin America
11.6.1 Brazil
11.6.2 Argentina
11.6.3 Rest of Latin America
12. Company Profiles
12.1 Koninklijke Philips N.V.
12.1.1 Financial
12.1.2 Products/ Services Offered
12.1.3 SWOT Analysis
12.1.4 The SNS view
12.2 ResMed
12.3 Medtronic
12.4 Fisher and Paykel Healthcare Limited
12.5 BD (U.S.)
12.6 Chart Industries, Inc.
12.7 Drägerwerk
12.8 AG & Co. KGaA
12.9 Hamilton Medical
12.10 Teleflex Incorporated
12.11 3M
13. Competitive Landscape
13.1 Competitive Benchmark
13.2 Market Share Analysis
13.3 Recent Developments
14. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Cell Freezing Media Market size was estimated at USD153.59 million in 2023 and is expected to reach USD 351.34 million by 2032 with a growing CAGR of 9.63% during the forecast period of 2024-2032.
The Molecular Diagnostics Market Size was USD 15.35 Billion in 2023, and expected to reach USD 32.37 Billion by 2032, and grow at a CAGR of 9.07%.
The Toxoid Vaccine Market Size was worth US$ 6 billion in 2023 and is estimated to reach US$ 9 billion by 2032, growing at a CAGR of 4.9% by 2024-2032.
The Wound Closure Market size was estimated USD 17.81 billion in 2023 and is expected to reach USD 28.6 billion by 2031 at a CAGR of 6.1% during the forecast period of 2024-2031.
The Healthcare Provider Network Management Market Size was valued at $4.23 Bn in 2023 & will reach $13.02 Bn by 2031 & grow at a CAGR of 15% by 2024-2031.
The Cell Reprogramming Market size was valued at US$ 406 million in 2023 and is projected to reach over US$ 725 million by 2031 with an increasing CAGR of 8.53% during the forecast period 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
